Skip to Primary Navigation

Skip to main content

Texas sues Johnson & Johnson, Kenvue, alleges deceptive Tylenol marketing

Tylenol caplets
Photo: Justin Sullivan/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

The suit hinges on violations of Texas law and could have broader ramifications for pharmaceuticals.

The Texas Attorney General (AG) is suing Johnson & Johnson and Kenvue, the maker of Tylenol, for allegedly deceptively marketing the popular pain medication as safe for use by pregnant women.

The Texas AG’s suit contends that Kenvue willfully ignored evidence that early exposure to the drug’s single active

, , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience